cdmo.directory
← Compare landing

Genevoyager (Wuhan) Co., Ltd. vs ProBioGen AG

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/genevoyager-2/probiogen

CategoryGenevoyager (Wuhan) Co., Ltd.ProBioGen AG
Listed sitebothcdmo
SummaryLeading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.ProBioGen is a fully integrated CDMO specializing in development and GMP manufacturing of therapeutic proteins, viral vectors, and vaccines, with proprietary platforms including CHO.RiGHT® for cell line development and AGE1.CR.pIX® for vaccine production.
Services
  • Translational Research
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
Modalities
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
Locations
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
  • Headquarters, Berlin, Berlin, Germany
  • Office, Berlin, Berlin, Germany
Certifications
  • China · Identifier: High-tech Enterprise (高新技术企业)
  • EMA · Identifier: GMP compliant
  • FDA · Identifier: GMP compliant
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.